Dmitry Dzhagarov at 09:54, 8 December 2023

2023-12-08T09:54:47Z

← Older revision		Revision as of 09:54, 8 December 2023
Line 1:		Line 1:
	'''Geroprotectors''' are substances that slow down aging process and can be used as senotherapeutics for prevention of age-related diseases.<ref>Moskalev, A. A. (2023). Potential Geroprotectors–From Bench to Clinic. Biochemistry (Moscow), 88(11), 1732-1738. https://doi.org/10.1134/S0006297923110056</ref><ref>Janssens, G. E., & Houtkooper, R. H. (2020). Identification of longevity compounds with minimized probabilities of side effects. Biogerontology, 21(6), 709-719. PMID: 32562114 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541369/ PMC7541369] DOI: 10.1007/s10522-020-09887-7</ref><ref>Liu, J. K. (2022). Antiaging agents: safe interventions to slow aging and healthy life span extension. Natural Products and Bioprospecting, 12(1), 1-36. PMID 35534591 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086005 PMC 9086005] doi:10.1007/s13659-022-00339-y</ref> Geroprotectors can improve functioning of various organ systems and enhance their homeostatic capabilities.		'''Geroprotectors''' are substances that slow down aging process and can be used as senotherapeutics for prevention of age-related diseases.<ref>Moskalev, A. A. (2023). Potential Geroprotectors–From Bench to Clinic. Biochemistry (Moscow), 88(11), 1732-1738. https://doi.org/10.1134/S0006297923110056</ref><ref>Janssens, G. E., & Houtkooper, R. H. (2020). Identification of longevity compounds with minimized probabilities of side effects. Biogerontology, 21(6), 709-719. PMID: 32562114 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541369/ PMC7541369] DOI: 10.1007/s10522-020-09887-7</ref><ref>Liu, J. K. (2022). Antiaging agents: safe interventions to slow aging and healthy life span extension. Natural Products and Bioprospecting, 12(1), 1-36. PMID 35534591 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086005 PMC 9086005] doi:10.1007/s13659-022-00339-y</ref> Geroprotectors can improve functioning of various organ systems and enhance their homeostatic capabilities.

	There is a database of geroprotectors, [http://www.geroprotectors.org Geroprotectors], which structures data on studies of potential geroprotectors.<ref>Moskalev, A., Chernyagina, E., de Magalhães, J. P., Barardo, D., Thoppil, H., Shaposhnikov, M., ... & Zhavoronkov, A. (2015). Geroprotectors. org: a new, structured and curated database of current therapeutic interventions in aging and age-related disease. Aging (Albany NY), 7(9), 616. PMID: 26342919 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600621 PMC4600621] DOI: 10.18632/aging.100799</ref> There is also [[Human Ageing Genomic Resources#DrugAge\|DrugAge]] (http://genomics.senescence.info/drugs/), a curated database of lifespan-extending drugs and compounds.<ref>Barardo, D., Thornton, D., Thoppil, H., Walsh, M., Sharifi, S., Ferreira, S., ... & de Magalhães, J. P. (2017). The DrugAge database of aging‐related drugs. Aging cell, 16(3), 594-597. PMID: 28299908 [[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418190/ PMC5418190]] DOI: 10.1111/acel.12585</ref>		There is a database of geroprotectors, [http://www.geroprotectors.org Geroprotectors], which structures data on studies of potential geroprotectors.<ref>Moskalev, A., Chernyagina, E., de Magalhães, J. P., Barardo, D., Thoppil, H., Shaposhnikov, M., ... & Zhavoronkov, A. (2015). Geroprotectors. org: a new, structured and curated database of current therapeutic interventions in aging and age-related disease. Aging (Albany NY), 7(9), 616. PMID: 26342919 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600621 PMC4600621] DOI: 10.18632/aging.100799</ref> There is also [[Human Ageing Genomic Resources#DrugAge\|DrugAge]] (http://genomics.senescence.info/drugs/), a curated database of lifespan-extending drugs and compounds.<ref>Barardo, D., Thornton, D., Thoppil, H., Walsh, M., Sharifi, S., Ferreira, S., ... & de Magalhães, J. P. (2017). The DrugAge database of aging‐related drugs. Aging cell, 16(3), 594-597. PMID: 28299908 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418190/ PMC5418190] DOI: 10.1111/acel.12585</ref>

	== References ==		== References ==

Dmitry Dzhagarov: Created page with "'''Geroprotectors''' are substances that slow down aging process and can be used as senotherapeutics for prevention of age-related diseases.Moskalev, A. A. (2023). Potential Geroprotectors–From Bench to Clinic. Biochemistry (Moscow), 88(11), 1732-1738. https://doi.org/10.1134/S0006297923110056Janssens, G. E., & Houtkooper, R. H. (2020). Identification of longevity compounds with minimized probabilities of side effects. Biogerontology, 21(6), 709-719. PM..."

2023-12-08T09:52:54Z

Created page with "'''Geroprotectors''' are substances that slow down aging process and can be used as senotherapeutics for prevention of age-related diseases.<ref>Moskalev, A. A. (2023). Potential Geroprotectors–From Bench to Clinic. Biochemistry (Moscow), 88(11), 1732-1738. https://doi.org/10.1134/S0006297923110056</ref><ref>Janssens, G. E., & Houtkooper, R. H. (2020). Identification of longevity compounds with minimized probabilities of side effects. Biogerontology, 21(6), 709-719. PM..."

New page

'''Geroprotectors''' are substances that slow down aging process and can be used as senotherapeutics for prevention of age-related diseases.<ref>Moskalev, A. A. (2023). Potential Geroprotectors–From Bench to Clinic. Biochemistry (Moscow), 88(11), 1732-1738. https://doi.org/10.1134/S0006297923110056</ref><ref>Janssens, G. E., & Houtkooper, R. H. (2020). Identification of longevity compounds with minimized probabilities of side effects. Biogerontology, 21(6), 709-719. PMID: 32562114 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541369/ PMC7541369] DOI: 10.1007/s10522-020-09887-7</ref><ref>Liu, J. K. (2022). Antiaging agents: safe interventions to slow aging and healthy life span extension. Natural Products and Bioprospecting, 12(1), 1-36. PMID 35534591 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086005 PMC 9086005] doi:10.1007/s13659-022-00339-y</ref> Geroprotectors can improve functioning of various organ systems and enhance their homeostatic capabilities.

There is a database of geroprotectors, [http://www.geroprotectors.org Geroprotectors], which structures data on studies of potential geroprotectors.<ref>Moskalev, A., Chernyagina, E., de Magalhães, J. P., Barardo, D., Thoppil, H., Shaposhnikov, M., ... & Zhavoronkov, A. (2015). Geroprotectors. org: a new, structured and curated database of current therapeutic interventions in aging and age-related disease. Aging (Albany NY), 7(9), 616. PMID: 26342919 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600621 PMC4600621] DOI: 10.18632/aging.100799</ref> There is also [[Human Ageing Genomic Resources#DrugAge|DrugAge]] (http://genomics.senescence.info/drugs/), a curated database of lifespan-extending drugs and compounds.<ref>Barardo, D., Thornton, D., Thoppil, H., Walsh, M., Sharifi, S., Ferreira, S., ... & de Magalhães, J. P. (2017). The DrugAge database of aging‐related drugs. Aging cell, 16(3), 594-597. PMID: 28299908 [[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418190/ PMC5418190]] DOI: 10.1111/acel.12585</ref>

== References ==
<references />

[[Category:Database]]
[[Category:Drafts]]
[[Category:Drugs]]
[[Category:Lifespan interventions]]
[[Category:Main list]]
[[Category:Stub]]

Geroprotectors - Revision history

Dmitry Dzhagarov at 09:54, 8 December 2023